Joep MA Lange

Persistent immune activation in HIV-1 infection is associated with progression to AIDS

Mette D. Hazenberg, Sigrid A. Otto, Birgit HB van Benthem et al. · AIDS · 2003 · 774 citations

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

Marieke den Brinker, Ferdinand W.N.M. Wit, Pauline M. E. Wertheim-van Dillen et al. · AIDS · 2000 · 396 citations

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

Norbert A. Foudraine, Richard M. W. Hoetelmans, Joep MA Lange et al. · The Lancet · 1998 · 172 citations

Drug Concentrations, Medicine, Human Retrovirus +7

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

Remko van Leeuwen, Christine Katlama, Robert L. Murphy et al. · AIDS · 2003 · 171 citations

Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study

Monique H. Reijers, Gerrit Jan Weverling, Suzanne Jurriaans et al. · The Lancet · 1998 · 160 citations

Hiv/aids Counselling, Amsterdam Duration, Treatment And Prevention +8